Work

The effect of adding a selective FAK inhibitor AMP945 to FOLFIRINOX in a model of pancreatic cancer.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.e15128

Authors: Christopher Burns, Kendelle Murphy, Terrie-Anne Cock, Mark Devlin, David Herrmann, Paul Timpson

Institution: Garvan Institute of Medical Research

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379333282

Cites:

Cited by: 6

Related to: 10